#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian epithelial cancer Chronic cutaneous lupus erythematosus Paraneoplastic neurological syndrome Congenital nephrogenic diabetes insipidus Von Willebrand's disease Atypical haemolytic uraemic syndrome Liposarcoma recurrent Neurotrophic keratopathy Pouchitis Microvillous inclusion disease Dent's disease Congenital hypotransferrinaemia Transitional cell carcinoma Malignant melanoma Chondrodystrophy More trials…

    Learn about Rare Diseases

    Progressive multifocal leukoencephalopathy – Treatment Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Undifferentiated sarcoma – Trials in Disease Chondrosarcoma – Basic Information Mantle cell lymphoma – Diagnostics Idiopathic pulmonary fibrosis – Trials in Disease Hereditary angioedema Congenital hypotransferrinaemia – Life with Disease Mucopolysaccharidosis Nephroblastoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alternaria Alternata Extract Rasburicase Phenprocoumon Polatuzumab Vedotin Rifaximin Ozanimod Hydrochloride ULIXERTINIB Neridronate Sodium Diltiazem Hydrochloride Sodium Phosphate Bisoprolol Gskvx000000014593 4-IODOPHENYLALANINE I-131 177LU-FAP-2286 Bomedemstat Gfh925 Dapirolizumab Pegol Mycophenolate Mofetil VAMIFEPORT TRIHYDROCHLORIDE Isosorbide Dinitrate More therapies…

    Learn about Your Condition

    Anal cancer Dermatomyositis Ventricular tachycardia Acquired haemophilia Alveolar bone defect Strongyloidiasis Premature rupture of membranes Hepatic adenoma Myotonic dystrophy Pigmentary glaucoma Intracranial aneurysm Muscle hypertrophy Hyperadrenocorticism Cardiogenic shock Fibrosarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Embolism

  • Comparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    • Enoxaparin Sodium
    • Apixaban
    Bulgaria Hungary Latvia Lithuania Poland Romania

  • Study of REGN7508 versus apixaban for treating and preventing cancer-associated blood clots in adults with solid or blood cancers

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Regn7508
    • Apixaban
    Bulgaria Romania

  • A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    Belgium Bulgaria Czechia France Germany Poland +2

  • A study to compare REGN7508 and acetylsalicylic acid for preventing blood clots in adults undergoing elective total knee replacement.

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Regn7508
    • Acetylsalicylic Acid
    Greece Italy Spain

  • A study to compare how asundexian is absorbed in healthy adults using different formulations and the effect of food for the prevention of blood clots.

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Asundexian
    Germany

  • Study comparing apixaban tablets to test if they work the same way in the body in healthy volunteers who have not eaten

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Apixaban
    Spain
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!